NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $36,428,000 | -15.8% | 11,383,721 | 0.0% | 0.01% | -11.1% |
| Q2 2022 | $43,258,000 | -29.5% | 11,383,721 | 0.0% | 0.01% | -18.2% |
| Q1 2022 | $61,358,000 | -60.1% | 11,383,721 | 0.0% | 0.01% | -56.0% |
| Q4 2021 | $153,794,000 | -24.8% | 11,383,721 | 0.0% | 0.02% | -28.6% |
| Q3 2021 | $204,452,000 | +4.7% | 11,383,721 | 0.0% | 0.04% | +6.1% |
| Q2 2021 | $195,345,000 | -14.2% | 11,383,721 | 0.0% | 0.03% | -17.5% |
| Q1 2021 | $227,674,000 | 0.0% | 11,383,721 | -15.0% | 0.04% | -4.8% |
| Q4 2020 | $227,674,000 | -9.4% | 13,392,612 | -11.6% | 0.04% | -19.2% |
| Q3 2020 | $251,386,000 | -28.4% | 15,152,846 | +0.0% | 0.05% | -33.3% |
| Q2 2020 | $350,909,000 | +24.8% | 15,151,481 | -3.8% | 0.08% | +5.4% |
| Q1 2020 | $281,084,000 | -19.5% | 15,746,960 | -2.6% | 0.07% | +1.4% |
| Q4 2019 | $349,127,000 | +16.2% | 16,174,579 | -2.0% | 0.07% | +7.4% |
| Q3 2019 | $300,566,000 | -34.9% | 16,500,943 | +27.1% | 0.07% | -33.3% |
| Q2 2019 | $461,839,000 | +6.0% | 12,980,300 | +0.1% | 0.10% | +3.0% |
| Q1 2019 | $435,507,000 | +23.3% | 12,961,558 | +20.7% | 0.10% | +12.5% |
| Q4 2018 | $353,069,000 | -24.8% | 10,741,365 | +39.4% | 0.09% | -11.1% |
| Q3 2018 | $469,584,000 | +41.0% | 7,703,118 | +13.0% | 0.10% | +33.8% |
| Q2 2018 | $332,984,000 | -9.8% | 6,819,244 | +96.3% | 0.07% | -11.9% |
| Q1 2018 | $369,216,000 | +205.7% | 3,474,653 | +71.8% | 0.08% | +211.1% |
| Q4 2017 | $120,764,000 | +5036.7% | 2,022,162 | +1233.4% | 0.03% | +2600.0% |
| Q4 2014 | $2,351,000 | +26.5% | 151,659 | -1.5% | 0.00% | 0.0% |
| Q3 2014 | $1,858,000 | +27.4% | 153,928 | +35.4% | 0.00% | – |
| Q2 2014 | $1,458,000 | +11.2% | 113,723 | +5.1% | 0.00% | – |
| Q1 2014 | $1,311,000 | – | 108,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |